An inactivating point mutation in exon 23 of the Dmd gene in mdx mice leads to dystrophin deficiency that models molecular aspects of DMD in skeletal and cardiac muscle [5]. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.